Patents by Inventor Christine Mack

Christine Mack has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Hybrid polypeptides with selectable properties
    Publication number: 20060293232
    Abstract: The present invention relates generally to novel, selectable hybrid polypeptides useful as agents for the treatment and prevention of metabolic diseases and disorders which can be alleviated by control plasma glucose levels, insulin levels, and/or insulin secretion, such as diabetes and diabetes-related conditions. Such conditions and disorders include, but are not limited to, hypertension, dyslipidemia, cardiovascular disease, eating disorders, insulin-resistance, obesity, and diabetes mellitus of any kind, including type 1, type 2, and gestational diabetes.
    Type: Application
    Filed: August 17, 2005
    Publication date: December 28, 2006
    Applicant: Amylin Pharmaceuticals, Inc.
    Inventors: Odile Levy, Michael Hanley, Carolyn Jodka, Diana Lewis, Christopher Soares, Soumitra Ghosh, Lawrence D'Souza, David Parkes, Christine Mack
  • Hybrid polypeptides with selectable properties
    Publication number: 20060094652
    Abstract: The present invention relates generally to novel, selectable hybrid polypeptides useful as agents for the treatment and prevention of metabolic diseases and disorders which can be alleviated by control plasma glucose levels, insulin levels, and/or insulin secretion, such as diabetes and diabetes-related conditions. Such conditions and disorders include, but are not limited to, hypertension, dyslipidemia, cardiovascular disease, eating disorders, insulin-resistance, obesity, and diabetes mellitus of any kind, including type 1, type 2, and gestational diabetes.
    Type: Application
    Filed: February 11, 2005
    Publication date: May 4, 2006
    Inventors: Odile Levy, Michael Hanley, Carolyn Jodka, Diana Lewis, Christopher Soares, Soumitra Ghosh, Lawrence D'Souza, David Parkes, Christine Mack
  • Methods for affecting body composition
    Publication number: 20050197287
    Abstract: Methods for affecting body composition include the use of amylin or amylin agonist(s). Total body weight may be reduced, maintained or even increased; however, the body fat is reduced or body fat gain is prevented, while lean body mass is maintained or increased.
    Type: Application
    Filed: May 20, 2004
    Publication date: September 8, 2005
    Inventors: Christine Mack, Jonathan Roth